The U.S. Food and Drug Administration (FDA) publishes a monthly Import Refusal Report (IRR), which details shipments refused entry into the United States. This report is a key monitoring signal for product quality and compliance risks at the border. By summarizing refusals by country/area and product category (industry code), the IRR helps companies identify recurring issues, prioritize corrective actions, and reduce the likelihood of repeat refusals.